Latest Stories
Q4 Earnings Highlights: Boston Beer (NYSE:SAM) Vs The Rest Of The Beverages, Alcohol, and Tobacco Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Boston Beer (NYSE:SAM) and the best and worst performers in the beverages, alcohol, and tobacco industry.
Perishable Food Stocks Q4 Recap: Benchmarking Tyson Foods (NYSE:TSN)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Tyson Foods (NYSE:TSN) and the best and worst performers in the perishable food industry.
Gaming Solutions Stocks Q4 Results: Benchmarking Light & Wonder (NASDAQ:LNW)
Wrapping up Q4 earnings, we look at the numbers and key takeaways for the gaming solutions stocks, including Light & Wonder (NASDAQ:LNW) and its peers.
Spotting Winners: Alignment Healthcare (NASDAQ:ALHC) And Health Insurance Providers Stocks In Q4
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Alignment Healthcare (NASDAQ:ALHC) and the rest of the health insurance providers stocks fared in Q4.
Unpacking Q4 Earnings: Grand Canyon Education (NASDAQ:LOPE) In The Context Of Other Education Services Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Grand Canyon Education (NASDAQ:LOPE) and the rest of the education services stocks fared in Q4.
Q4 Earnings Highlights: iRhythm (NASDAQ:IRTC) Vs The Rest Of The Patient Monitoring Stocks
Looking back on patient monitoring stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including iRhythm (NASDAQ:IRTC) and its peers.
Q4 Earnings Outperformers: Amgen (NASDAQ:AMGN) And The Rest Of The Therapeutics Stocks
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how therapeutics stocks fared in Q4, starting with Amgen (NASDAQ:AMGN).
Spectrum Brands (SPB): Buy, Sell, or Hold Post Q4 Earnings?
Spectrum Brands has gotten torched over the last six months - since October 2024, its stock price has dropped 24.2% to a new 52-week low of $69.23 per share. This might have investors contemplating their next move.
3 Reasons to Sell FSLY and 1 Stock to Buy Instead
Over the past six months, Fastly’s shares (currently trading at $6.33) have posted a disappointing 14% loss while the S&P 500 was down 3.4%. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.
Vertical Software Stocks Q4 In Review: Alarm.com (NASDAQ:ALRM) Vs Peers
As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the vertical software industry, including Alarm.com (NASDAQ:ALRM) and its peers.